[Adverse effects of neurolepitcs from the biochemical viewpoint].
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects; D001921:Brain / Q000201:enzymology; D001923:Brain Chemistry / Q000187:drug effects; D002540:Cerebral Cortex / Q000187:drug effects; D004027:Diencephalon / Q000201:enzymology; D004734:Energy Metabolism / Q000187:drug effects; D005116:Extrapyramidal Tracts / Q000187:drug effects; D006801:Humans; D008928:Mitochondria / Q000187:drug effects; D009457:Neuroglia / Q000187:drug effects; D009708:Nucleotidases / Q000378:metabolism; D010640:Phenothiazines; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000009:adverse effects*
D014150:Antipsychotic Agents; D010640:Phenothiazines; D014149:Tranquilizing Agents; D009708:Nucleotidases
Begleitwirkungen von Neuroleptika aus biochemischer Sicht